SP
CME icon

Sarasin & Partners’s CME Group CME Stock Holding History

Sarasin & Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290M Buy
1,314,268
+383,581
+41% +$106M 3.4% 8
2026
Q1 		$275M Sell
930,687
-162,250
-15% -$48.2M 3.35% 8
2025
Q4 		$298M Sell
1,092,937
-32,308
-3% -$8.78M 3.1% 10
2025
Q3 		$306M Buy
1,125,245
+110,373
+11% +$30M 3.01% 11
2025
Q2 		$280M Sell
1,014,872
-157,718
-13% -$42.9M 2.78% 13
2025
Q1 		$311M Sell
1,172,590
-563,121
-32% -$139M 3.37% 10
2024
Q4 		$403M Sell
1,735,711
-19,904
-1% -$4.58M 4.45% 8
2024
Q3 		$387M Sell
1,755,615
-246,052
-12% -$50.9M 3.65% 10
2024
Q2 		$394M Sell
2,001,667
-282,620
-12% -$58.4M 3.49% 8
2024
Q1 		$492M Buy
2,284,287
+30,320
+1% +$6.37M 4.84% 4
2023
Q4 		$475M Sell
2,253,967
-233,174
-9% -$49.8M 5.22% 4
2023
Q3 		$498M Sell
2,487,141
-200,995
-7% -$40M 6.22% 3
2023
Q2 		$498M Sell
2,688,136
-1,959,057
-42% -$362M 5.78% 1
2023
Q1 		$960M Buy
4,647,193
+2,464,368
+113% +$446M 5.17% 2
2022
Q4 		$367M Buy
2,182,825
+442,027
+25% +$76.8M 4.81% 2
2022
Q3 		$308M Buy
1,740,798
+148,854
+9% +$29.4M 4.27% 3
2022
Q2 		$326M Buy
1,591,944
+9,809
+0.6% +$2.08M 4.11% 4
2022
Q1 		$376M Sell
1,582,135
-502,435
-24% -$118M 3.78% 4
2021
Q4 		$476M Buy
2,084,570
+37,669
+2% +$8.29M 4.34% 2
2021
Q3 		$396M Buy
2,046,901
+163,620
+9% +$33.1M 3.99% 2
2021
Q2 		$401M Buy
1,883,281
+28,126
+2% +$5.94M 4.18% 2
2021
Q1 		$379M Buy
1,855,155
+75,227
+4% +$14.8M 4.47% 1
2020
Q4 		$324M Buy
1,779,928
+260,135
+17% +$44.2M 4.29% 1
2020
Q3 		$254M Buy
1,519,793
+122,202
+9% +$20.6M 3.68% 4
2020
Q2 		$227M Buy
1,397,591
+59,504
+4% +$10.7M 3.63% 6
2020
Q1 		$231M Buy
1,338,087
+17,364
+1% +$3.46M 4.55% 1
2019
Q4 		$265M Buy
1,320,723
+14,178
+1% +$2.91M 4.05% 1
2019
Q3 		$276M Buy
1,306,545
+31,497
+2% +$6.58M 4.57% 1
2019
Q2 		$248M Buy
1,275,048
+281,767
+28% +$51.9M 4.33% 1
2019
Q1 		$163M Sell
993,281
-28,931
-3% -$5.11M 3.15% 11
2018
Q4 		$192M Buy
1,022,212
+62,421
+7% +$11.5M 4.18% 2
2018
Q3 		$163M Buy
959,791
+21,306
+2% +$3.59M 3.08% 10
2018
Q2 		$154M Sell
938,485
-65,753
-7% -$10.7M 3.02% 11
2018
Q1 		$162M Buy
1,004,238
+234,845
+31% +$37.4M 3.18% 8
2017
Q4 		$112M Buy
769,393
+300,204
+64% +$42.8M 2.18% 17
2017
Q3 		$63.7M Buy
469,189
+119,774
+34% +$15.1M 1.28% 34
2017
Q2 		$43.8M Buy
+349,415
New +$41.8M 0.86% 42

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Sarasin & Partners's CME Position: Q2 2026 in Review

Sarasin & Partners increased its CME Group (CME) stake by 41% in Q2 2026, buying an estimated $106M and bringing the position to 1,314,268 shares worth $290M. The position accounts for 3.4% of the portfolio, ranked #8.

Sarasin & Partners first reported a position in CME in Q2 2017 and has held it in 37 quarters since. The position peaked at $960M in Q1 2023. 593 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sarasin & Partners held 1,314,268 shares of CME Group worth $290M as of Q2 2026.
  • Sarasin & Partners bought 383,581 CME Group shares in Q2 2026, an estimated $106M.
  • CME Group made up 3.4% of Sarasin & Partners's portfolio in Q2 2026, its #8 holding.
  • Sarasin & Partners first reported a position in CME Group in Q2 2017 and has held it in 37 quarters since.
  • Sarasin & Partners's CME Group position peaked at $960M in Q1 2023.
  • 593 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sarasin & Partners's 13F filing for Q2 2026, filed 7 Jul 2026.